AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 86 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $16,000 | -23.8% | 22,440 | -12.9% | 0.00% | – |
| Q1 2019 | $21,000 | -30.0% | 25,761 | +38.4% | 0.00% | – |
| Q4 2018 | $30,000 | -53.8% | 18,616 | -34.4% | 0.00% | – |
| Q2 2018 | $65,000 | +35.4% | 28,399 | +72.5% | 0.00% | – |
| Q1 2018 | $48,000 | -31.4% | 16,467 | -35.0% | 0.00% | – |
| Q4 2017 | $70,000 | +141.4% | 25,323 | -27.0% | 0.00% | – |
| Q4 2014 | $29,000 | -76.0% | 34,680 | -47.5% | 0.00% | – |
| Q2 2014 | $121,000 | +181.4% | 66,072 | +130.4% | 0.00% | – |
| Q1 2014 | $43,000 | -70.7% | 28,677 | -64.3% | 0.00% | – |
| Q4 2013 | $147,000 | +67.0% | 80,217 | +87.1% | 0.00% | – |
| Q3 2013 | $88,000 | -95.8% | 42,883 | -94.9% | 0.00% | -100.0% |
| Q2 2013 | $2,102,000 | +42.0% | 841,034 | +317.4% | 0.00% | +100.0% |
| Q1 2013 | $1,480,000 | – | 201,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
| SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
| WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
| Caption Management, LLC | 748,200 | $503,000 | 0.02% |
| Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
| Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |